SCHEMBL845841

SCHEMBL845841

O=C(Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)c3ncccc3-c3ccccc3)cc2)cc1)[C@@H]1CCCN1C(=O)c1ncccc1-c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
HCRTR2 O43614 2/20 0.44
DGAT1 O75907 2/20 0.43
PABPC1 P11940 1/20 0.43
ROCK2 O75116 1/20 0.43
ALDH1A1 P00352 3/20 0.43
MAPK1 P28482 1/20 0.43
HTT P42858 1/20 0.43
PORCN Q9H237 2/20 0.43
KCNH2 Q12809 1/20 0.42
HCRTR1 O43613 1/20 0.42
KDM4E B2RXH2 1/20 0.42
LMNA P02545 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13272509 1.00 TRPV1 (0.45) TRPV1CYP2C9CYP2C19HCRTR2DGAT1
SCHEMBL845704 0.95 TRPV1 (0.48) TRPV1CYP2C9CYP2C19HCRTR2DGAT1
SCHEMBL845699 0.92 RHOC (0.48) DGAT1HTTHCRTR1
SCHEMBL845114 0.89 EP300 (0.46) TRPV1DGAT1ALDH1A1HTTLMNA
SCHEMBL845640 0.89 ALDH1A1 (0.49) TRPV1HCRTR2ROCK2ALDH1A1HCRTR1
SCHEMBL10119343 0.88 ALDH1A1 (0.44) CYP2C9CYP2C19HCRTR2DGAT1PABPC1
SCHEMBL10119346 0.88 RHOC (0.45) HCRTR2DGAT1ALDH1A1HCRTR1
SCHEMBL13272491 0.87 TRPV1 (0.38) TRPV1CYP2C9CYP2C19HCRTR2DGAT1
SCHEMBL845442 0.86 CYP2C9 (0.43) TRPV1CYP2C9CYP2C19PABPC1ALDH1A1
SCHEMBL845374 0.86 PABPC1 (0.51) CYP2C9CYP2C19HCRTR2DGAT1PABPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
EP-1893573-B1 INHIBITORS OF HCV REPLICATION BRISTOL MYERS SQUIBB CO (US) 2010-07-21 EP disclosed